The evolution of TAVI performance overtime: an overview of systematic reviews

C Angioletti, G Moretti, S Manetti, L Pastormerlo… - BMC Cardiovascular …, 2024 - Springer
Background Transcatheter aortic valve implantation (TAVI) is a well-established treatment
for high and intermediate-risk patients with severe aortic stenosis (AS). Recent studies have …

Is There a Future for Minimal Access and Robots in Cardiac Surgery?

G Faerber, M Mukharyamov, T Doenst - Journal of Cardiovascular …, 2023 - mdpi.com
Minimally invasive techniques in cardiac surgery have found increasing use in recent years.
Both patients and physicians often associate smaller incisions with improved outcomes (ie …

Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model

S Katahira, M Barth, R Döpp, Y Sugimura… - Frontiers in …, 2024 - frontiersin.org
Aims Chronic kidney disease (CKD) is a risk factor for the development of cardiovascular
diseases, eg, atherosclerosis and calcific aortic valve disease, leading inevitably to valve …

Transcatheter Versus Surgical Aortic Valve Replacement in Patients at Low Risk: Long-Term Outcomes From the Three Pivotal Randomised Trials Determined by …

A Messori, S Trippoli, V Fadda - Heart, Lung and Circulation, 2024 - heartlungcirc.org
Transcatheter Versus Surgical Aortic Valve Replacement in Patients at Low Risk: Long-Term
Outcomes From the Three Pivotal Randomised Trials Determined by Reconstruction of …

[HTML][HTML] Tislelizumab plus chemotherapy vs. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review …

A Messori, M Rivano, M Chiumente… - Chinese Clinical …, 2023 - cco.amegroups.org
Background: Pembrolizumab (PEM) and tislelizumab (TIS), in combination with
chemotherapy, have demonstrated significant clinical benefits in first-line treatment of …

Risk Scores (Risk Stratification)

S Singh, P Vallabhajosyula - Transcatheter Aortic Valve Implantation - taylorfrancis.com
Risk stratification aims to have enough patient-centric data to have an informed discussion
with the patient, with the goal of “doing the right procedure for the right patient at the right …

[引用][C] Chronic kidney disease and aortic valve replacement: Let's filter the evidence!

M Simonato, D Dvir, MG Nanna - Trends in Cardiovascular Medicine, 2023 - europepmc.org
Chronic kidney disease and aortic valve replacement: Let's filter the evidence! - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …